Related Experiment Video
Updated: May 25, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Summary
Commercial weight management programs are more effective and cost-efficient for obesity treatment than primary care services. NHS funding for these commercial options could be a cost-effective public health intervention.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Obesity is a global epidemic, defined as a body mass index (BMI) of 30 kg/m² or higher.
- Approximately 25% of England's population is obese, highlighting a significant public health challenge.
- The Lighten Up trial investigated weight loss interventions in a primary care setting in Birmingham.
Discussion:
- The study compared commercial weight management programs with primary care-led services and minimal intervention.
- Commercial programs demonstrated greater effectiveness and cost-efficiency compared to primary care-based services.
- The most effective intervention resulted in an average weight loss of 1.3 kg/m².
Key Insights:
- Commercial weight management programs offer a superior and more economical approach to obesity treatment.
- A cost per life year saved of £77 suggests significant economic value.
- Implementing commercial weight loss programs as an NHS-funded service is a potentially cost-effective strategy.
Outlook:
- Further research could explore long-term adherence and broader implementation strategies.
- Investigating patient satisfaction and diverse population needs within commercial programs is warranted.
- The findings support the integration of evidence-based commercial weight management solutions into national health services.
More Related Videos
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...